PeterGregorCzarneckiMD

Critical Care, Hereditary Kidney Disease Genetics

Physician

Dr. Czarnecki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2010 - 2013
Mayo ClinicCritical Care Medicine, 2009 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Albert Ludwigs University Faculty of MedicineClass of 2005

PubMed

335 citations
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier, Kaleab Z. Abebe, Ronald D. Perrone, Vicente E. Torres, William E. Braun
The New England Journal of Medicine. 2014-12-10
14 citations
Multiple Myeloma Cells Depend on the DDI2/NRF1-mediated Proteasome Stress Response for Survival
Tianzeng Chen, Jenna Briere, Maria Moscvin, Peter G. Czarnecki, Kenneth C. Anderson
Blood Advances. 2021-10-14
178 citations
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Kaleab Z. Abebe, Arlene B. Chapman, Robert W. Schrier, William E. Braun
The New England Journal of Medicine. 2014-12-10

Abstracts/Posters

The Transmembrane Receptor Roundabout 1 (ROBO1) Is Necessary for Multiple Myeloma Proliferation and Homing to the Bone Marrow Niche
Peter G. Czarnecki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019